| 22-Mar-12 |
| GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from March 13, 2012 to March 22, 2012 (both days inclusive) for the purpose of Payment of Dividend & 53rd Annual General Meeting (AGM) of the Company to be held on March 22, 2012.
The dividend shall be paid to the entitled Members on or before April 03, 2012.
GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the 53rd Annual General Meeting (AGM) of the Company will be held on March 22, 2012.
GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the 53rd Annual General Meeting (AGM) of the Company will beheld on March 22, 2012,inter alia, to transact the following:
1. To consider and adopt the Audited Profit and Loss Account for the year ended December 31, 2011, the Balance Sheet as at that date
together with the Reports of the Directors and Auditors.
2. To declare Dividend on equity shares for the year ended December 31, 2011.
3. To appoint Auditors for the current year and to authorise the Board of Directors to fix their remuneration.
4.To appoint of Mr. Jaiboy John Phillips as
a Wholetime Director of the Company, with effect from February 06,2012, on remuneration, terms & conditions.
5. To appoint Mr.Jaiboy John Phillips as a Wholetime Director of the Company, with
effect from February 0 6, 2012, on remuneration, terms & conditions.(For more details kindly refer Corporate Announcements on www.bseindia.com).
(AsPer BSE Announcement Website Dated on 03/03/2012)
GlaxoSmithkline Consumer Healthcare Ltd has submitted to BSE a copy of the 53rd Annual General Meeting (AGM) of the Company held on March 22, 2012.
(As Per BSE Announcement Dated on 29.03.2012) |
| 29-Mar-11 |
| GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from March 15, 2011 to March 28, 2011 (both days inclusive) for the purpose of Payment of Dividend (Dividend of Rs. 25 per equity share and a Special Dividend of Rs. 25 per equity share) & 52nd Annual General Meeting (AGM) of the Company to be held on March 29, 2011.
GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the members at the 52nd Annual General Meeting (AGM) of the Company held on March 29, 2011, inter alia, have approved the following:
1. Approved the Audited Balance Sheet and Profit and Loss Account for the year ended December 31, 2010 together with the Directors' Report and Auditors Report thereon.
2. Approved and declared a dividend of Rs. 50.00 per equity share of Rs. 10 each for the year ended December 31, 2010.
3. Re-appointed M/s. PriceWaterhouse, Chartered Accountant, as the Auditors of the Company upto the conclusion of the next Annual General Meeting of the Company.
(As Per BSE Announcement Website dated on 29.03.2011)
GlaxoSmithkline Consumer Healthcare Ltd has submitted to BSE a copy of the minutes of the 52nd Annual General Meeting (AGM) of the members of the Company held on March 29, 2011.
(As Per BSE Announcement Website dated on 20.04.2011) |
| 23-Apr-10 |
| GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from April 13, 2010 to April 23, 2010 (both days inclusive) for the purpose of 51st Annual General Meeting (AGM) of the Company to be held on April 23, 2010.
GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the members at the 51st Annual General Meeting (AGM) of the Company held on April 23, 2010, inter alia, have accorded to the following:
1. Approved the Audited Balance Sheet and Profit and Loss Account for the year ended December 31, 2009 together with the Directors Report and Auditors Report thereon.
2. Approved and declared a final dividend of Rs. 18.00 per equity share of Rs. 10 each for the year ended December 31, 2009.
3. Re-appointed M/s. PriceWaterhouse, Chartered Accountants, as the Auditors of the Company upto the conclusion of the next Annual General Meeting of the Company.
4. Approved the appointment and terms of remuneration payable to Mr. Ramakrishnan Subramanian as Wholetime Director of the Company with effect from August 1, 2009.
5. Elected following Directors by Poll under the system of Proportional Representation under Section 265 of the Companies Act, 1956:
i. Mr. Kunal Kashyap
ii. Mr. P Dwarakanath
iii. Mr. Praveen K Gupta
iv. Mr. Subodh Bhargava
v. Mr. Naresh Dayal
vi. Mr. Mukesh H Butani
6. Approved the Terms of remuneration payable to Mr. Praveen K Gupta as Wholetime
Director of the Company with effect from April 24, 2010.
7. Approved the revision in maximum ceiling of Basic Salary and allowances payable to Mr. Zubair Almied, Managing Director w.e.f. April 01, 2010.
(As Per BSE Announcement Website dated on 23.04.2010)
GlaxoSmithkline Consumer Healthcare Ltd has submitted to BSE minutes of the proceedings of the Annual General Meeting (AGM) of the Company held on April 23, 2010.
(As Per BSE Announcement Dated on 12.05.2010) |
| 24-Apr-09 |
| AGM 24/04/2009
GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the members at the 50th Annual General Meeting (AGM) of the Company held on April 24, 2009, inter alia, have approved the following:
1. Approved the Audited Balance Sheet and Profit and Loss Account for the year ended December 31, 2008 together with the Directors' Report and Auditors Report thereon.
2. Approved final dividend of Rs. 5.00 per equity share of Rs 10 each for the year ended December 31, 2008 and confirmed the Interim Dividend amounting to Rs 10.00 per equity share of Rs 10 each already paid for the year ended December 31, 2008.
3. Re-appointed M/s Price Chartered Accountants, as the Auditors of the Company upto the conclusion of the next Annual General Meeting of the Company.
(As Per BSE Announcement Website dated on 24.04.2009)
GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the 50th Annual General Meeting (AGM) of the Company was held on April 24, 2009. The Company has submitted to BSE a copy of the duly approved minutes of the proceedings of the said Annual General Meeting.
(As Per BSE Announcement Website dated on 07.05.2009) |
| 25-Apr-08 |
| A.G.M. 25.04.2008
GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the 49th Annual General Meeting (AGM) of the members of the Company will be held on April 25, 2008, inter alia, to transact the following business:
1. To consider and adopt the Audited Profit and Loss Account for the year ended December 31, 2007, the Balance Sheet as at that date together with the Reports of the Directors and Auditors.
2. To confirm the interim Dividend aggregating to Rs 12 per equity share of Rs 10 each already paid for the year ended December 31, 2007.
3. To appoint Auditors for the current year and to authorise the Board of Directors to fix their remuneration.
4. To appoint Mr. Ramakrishan Subramanian as the Wholetime Director of the Company with effect from December 01, 2007 for a period of three years, on remuneration, terms & conditions.
5. Revision in the remuneration payable to Mr. Praveen K Gupta, Wholetime Director of the Company.
(As per BSE Announcement Website dated on 08/04/2008)
GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the members at the 49th Annual General Meeting (AGM) of the Company held on April 25, 2008, inter alia, have approved the following: 1. Approved the Audited Balance Sheet and Profit and Loss Account for the year ended December 31, 2007 together with the Directors Report and Auditors Report thereon. 2. Approved and confirmed the Interim Dividend amounting to Rs 12.00 per equity share of Rs 10 each already paid for the year ended December 31, 2007. 3. Re-appointed M/s. Price Waterhouse, Chartered Accountants, as the Auditors of the Company upto the conclusion of the next Annual General Meeting of the Company. 4. Approved the remuneration of Mr. Ramakrishnan Subramanian, Wholetime Director, who has been nominated by M/s. Horlicks Ltd under Articles 97-A of the Articles o Association of the Company. 5. Approved the variation in terms of appointment of Mr. Praveen K Gupta, Wholetime Director.
(As Per BSE Bulletin Dated on 02.05.2008)
GlaxoSmithkline Consumer Healthcare Ltd has informed BSE regarding Outcome of AGM held on April 25, 2008.
(As Per BSE Announcement Website Dated on 21.07.2008) |